Biophysical Profile: Complete Fetal Well-Being Assessment Guide

The biophysical profile (BPP) is a comprehensive assessment of fetal well-being that combines four ultrasound observations (fetal breathing movements, gross body movements, fetal tone, and amniotic fluid volume) with one non-stress test (fetal heart rate reactivity). The BPP was developed by Dr. Frank Manning in the 1980s and has become a standard tool for managing high-risk pregnancies. Each component is scored 0 or 2 points, with a total score ranging from 0-10. Scores of 8-10 (with normal fluid) are considered reassuring, 6 is equivocal requiring repeat testing, and ≤ 4 is abnormal and typically prompts delivery depending on gestational age. The BPP is primarily indicated for pregnancies at increased risk of fetal compromise including intrauterine growth restriction (IUGR), preeclampsia, decreased fetal movement, diabetes, post-term pregnancy, and oligohydramnios. Testing frequency typically ranges from twice weekly to daily depending on clinical situation. The examination takes approximately 30 minutes and poses no risk to mother or fetus. Abnormal BPP scores have strong correlation with fetal acidosis and stillbirth risk, making this test invaluable for timing delivery in complicated pregnancies.

Component 1: Non-Stress Test (NST)

Assessment: Fetal Heart Rate Reactivity

Normal (2 points):

• Reactive NST: At least 2 accelerations of fetal heart rate
• Acceleration criteria: Increase of at least 15 bpm above baseline
• Duration: Each acceleration lasting at least 15 seconds
• Time period: Within 20-40 minutes of observation

Abnormal (0 points):

• Non-reactive NST: Fewer than 2 accelerations in 40 minutes
• No accelerations: No fetal heart rate accelerations observed

Physiologic Basis:

• Fetal heart rate accelerations reflect intact fetal central nervous system
• Reactive NST indicates fetal neurologic well-being and absence of significant acidosis
• Non-reactive NST may indicate fetal sleep, acidosis, or neurologic compromise

Technical Aspects:

• Duration: Typically 20-40 minutes
• External monitoring: Fetal heart rate monitored externally
• Maternal perception: Mother may be asked to press button when she feels fetal movement
• Acoustic stimulation: May use vibroacoustic stimulation to attempt to elicit accelerations

Component 2: Fetal Breathing Movements

Assessment: Presence and Duration of Fetal Breathing

Normal (2 points):

• At least 1 episode of rhythmic fetal breathing movements
• Duration: Lasting at least 30 seconds
• Observation period: Within 30 minutes

Abnormal (0 points):

• Absence of fetal breathing: No breathing movements observed in 30 minutes
• Short episodes: Breathing episodes ＜ 30 seconds

Physiologic Basis:

• Fetal breathing movements reflect functional diaphragmatic activity
• Absence suggests fetal compromise, sleep state, or neurologic depression
• Breathing movements are influenced by gestational age and fetal behavioral states

Technical Aspects:

• M-mode or real-time: Used to document breathing movements
• Chest wall movement: Rhythmic inward and outward movement of fetal chest
• Excludes hiccups: Isolated hiccups not counted as breathing movements
• Gestational age consideration: Breathing movements more common after 30-32 weeks

Component 3: Gross Body Movements

Assessment: Large Fetal Body Movements

Normal (2 points):

• At least 3 discrete body movements:
  • Limb movements
  • Trunk movements
  • Rolling movements
• Duration: Within 30 minutes
• Quality: Movements should be definite and sustained

Abnormal (0 points):

• Fewer than 3 movements: Less than 3 discrete movements in 30 minutes
• Limited movement: Decreased overall activity

Physiologic Basis:

• Fetal movements reflect intact central nervous system function
• Decreased movements may indicate fetal compromise, sleep, or neurologic depression
• Movement patterns vary with fetal behavioral states (sleep-wake cycles)

Technical Aspects:

• Observation period: Up to 30 minutes
• Documentation: Movements documented in real-time
• Distinguishes: From small movements (hand, finger) which don't count
• Fetal sleep: May wait for fetus to awaken from sleep

Component 4: Fetal Tone

Assessment: Fetal Muscle Tone and Extension

Normal (2 points):

• At least 1 episode of active extension and return to flexion:
  • Limb extension with flexion return
  • Trunk extension with return to normal position
  • Hand opening with closing
• Observation: Within 30 minutes

Abnormal (0 points):

• No active movement: Either at rest or slow extension only
• No tone: Lacks normal fetal tone
• Fixed position: Fetus remains in same position

Physiologic Basis:

• Normal tone indicates intact neuromuscular function
• Absence of tone is a late sign of fetal compromise
• Tone is one of the last parameters to be lost in fetal deterioration

Technical Aspects:

• Subtle assessment: Requires careful observation
• Focus on limbs: Upper and lower extremities
• Extension and flexion: Active movement in both directions
• Gestational age: More easily assessed after 28 weeks

Component 5: Amniotic Fluid Volume

Assessment: Amniotic Fluid Index (AFI) or Single Deepest Pocket

Normal (2 points):

• AFI: ≥ 5 cm (some use > 8 cm)
• Single deepest pocket: ≥ 2 cm x 1 cm
• Adequate fluid: Sufficient amniotic fluid present

Abnormal (0 points):

• Oligohydramnios: AFI ＜ 5 cm (or ＜ 8 cm depending on criteria)
• Single deepest pocket: ＜ 2 cm x 1 cm
• Insufficient fluid: Decreased amniotic fluid volume

Physiologic Basis:

• Amniotic fluid reflects placental function and fetal renal function
• Decreased fluid indicates placental insufficiency or fetal renal compromise
• Oligohydramnios is associated with increased risk of cord compression and fetal distress

Technical Aspects:

• Four-quadrant AFI: Most commonly used
• Measurement: Deepest vertical pocket in each quadrant
• Exclusions: Cord and extremities excluded from measurements

Scoring Grid

Total Score Calculation:

• Sum of 5 components: Each component worth 0 or 2 points
• Total range: 0-10 points

Score Interpretation

BPP Score Categories:

Special Consideration for Amniotic Fluid:

• Fluid is critical: Normal score (8-10) requires normal fluid
• Oligohydramnios: Even if score 8/10 with abnormal fluid, management as equivocal or abnormal
• Isolated oligohydramnios: AFI ＜ 5 cm with otherwise normal BPP is concerning

Modified BPP (M-BPP):

• Components: NST + amniotic fluid only
• Scoring: Both normal or both abnormal
• Utility: Useful when full BPP not available
• Limitations: Less comprehensive than full BPP

Primary Indications

Conditions Associated with Increased Risk of Fetal Compromise:

Other Indications

Additional Situations Where BPP May Be Indicated:

• Antiphospholipid syndrome
• Systemic lupus erythematosus
• Chronic hypertension
• Renal disease
• Thrombophilia
• Cervical insufficiency after cerclage
• Preterm labor with tocolysis
• Placental abnormalities (previa, abruption)
• Rh sensitization
• Fetal anomalies
• Maternal obesity limiting monitoring

Normal BPP Score (8-10)

Characteristics:

• All components normal: Or only one component abnormal if fluid normal
• Reassuring: Indicates low risk of fetal compromise in next week
• Negative predictive value: > 99% for stillbirth in next week

Management:

• Continue antenatal testing: Per schedule (typically twice weekly)
• Routine prenatal care: Continue obstetric management
• No intervention required: Unless other clinical indications

Frequency of Testing:

• High risk: Twice weekly
• Very high risk: Daily or every other day
• Intermediate risk: Twice weekly to weekly

Equivocal BPP Score (6)

Characteristics:

• Two components abnormal: Any two components scoring 0
• Intermediate risk: Increased risk of fetal compromise
• Requires action: Further assessment needed

Management:

• Repeat BPP: Within 24 hours
• Consider delivery: If ≥ 34 weeks and persistent abnormal score
• Additional evaluation: May add Doppler studies, biophysical profile components

If Repeat Score Normal:

• Continue testing: Per schedule
• Increased vigilance: Consider more frequent testing

If Repeat Score Remains Abnormal:

• Strongly consider delivery: Especially ≥ 34 weeks
• Individualized: Based on gestational age, clinical situation, and patient preferences

Abnormal BPP Score (≤ 4)

Characteristics:

• Three or more components abnormal: Score of 4 or less
• High risk: Significant risk of fetal compromise and stillbirth
• Action required: Usually prompts delivery

Management by Gestational Age:

Urgent Delivery Indications:

• BPP 0-2: Any gestational age > 24 weeks
• BPP 4 with oligohydramnios: Any gestational age > 32-34 weeks
• Absent fetal tone: Very concerning finding
• Absence of breathing and movement: Especially if oligohydramnios present

Preterm Gestational Age (＜ 34 weeks)

Considerations:

• Balance risks: Fetal compromise vs. prematurity risks
• Individualized: No single correct approach
• Corticosteroids: If delivery likely ＜ 34 weeks
• Transfer: To facility with NICU if delivery anticipated

Management Options:

• Intensive monitoring: Hospitalization with continuous or very frequent monitoring
• Expectant management: With very intensive monitoring in selected cases
• Delivery: When risks of continuing pregnancy exceed risks of prematurity

Intrauterine Growth Restriction

BPP in IUGR:

• Increased frequency: More frequent testing than other indications
• Combined with Doppler: Doppler studies add important information
• Lower threshold for delivery: May deliver at lower BPP score than in other conditions
• Poor specificity: BPP has limited ability to detect acidosis in IUGR

Modified Approach:

• BPP + Doppler: Combined approach improves detection of compromise
• Cerebroplacental ratio: May add additional prognostic information
• ** ductus venosus**: In severe early-onset IUGR

Post-Term Pregnancy (> 40-41 weeks)

Indications:

• Routine surveillance: Twice weekly BPP or NST
• Amniotic fluid assessment: Particularly important as fluid normally decreases post-term
• Delivery timing: Typically by 41-42 weeks if BPP normal, earlier if abnormal

Management:

• Normal BPP: Continue twice weekly testing, deliver by 41-42 weeks
• Abnormal BPP: Recommend delivery at gestational age
• Oligohydramnios: Strong indication for delivery

Test Characteristics

Performance Metrics:

Clinical Implications:

• Excellent NPV: Normal BPP virtually excludes acidosis
• Moderate PPV: Abnormal BPP doesn't always indicate acidosis (some false positives)
• Gestational age dependent: Performance varies by gestational age and underlying condition

Limitations

Test Limitations:

• Subjectivity: Some components (tone, movements) have subjective interpretation
• Fetal sleep state: May affect results (especially breathing, movements)
• Maternal factors: Obesity, maternal position may affect visualization
• Interobserver variability: Different sonographers may interpret differently
• Time-consuming: Takes 30+ minutes, may not be available everywhere

Specific Limitations by Component:

• NST: May be non-reactive during fetal sleep
• Breathing: Variable with gestational age, influenced by fetal behavioral state
• Movements: Affected by fetal sleep, medications
• Tone: Subtle, may be difficult to assess
• Fluid: May be affected by membrane status, gestational age

How long does a biophysical profile take? A BPP typically takes 30-45 minutes total. The NST (heart rate monitoring) takes 20-40 minutes. The ultrasound portion takes approximately 10-15 minutes to observe all the required components (breathing, movements, tone, amniotic fluid). The total time depends on fetal activity - a very active fetus may complete all components quickly, while a fetus that is sleeping may take longer to observe the required movements.

Is the biophysical profile safe for my baby? Yes, the BPP is completely safe. It uses standard ultrasound imaging, which has no known harmful effects at diagnostic levels. The NST uses external monitors that detect the fetal heartbeat - no energy is transmitted to the fetus. The BPP poses no risk to mother or baby and can be repeated as frequently as clinically indicated.

What if my baby is sleeping during the BPP? Fetal sleep is a common reason for initially abnormal BPP scores. If your baby appears to be sleeping (not moving or breathing), the sonographer may wait longer, use acoustic stimulation (making a noise) to try to wake the baby, or reschedule the test for later. In many cases, the baby will wake during the observation period and complete the required movements. If the BPP is repeated in 24 hours and normalizes, it likely reflects fetal sleep during the initial test.

Does a normal BPP guarantee my baby is healthy? A normal BPP (score 8-10) is very reassuring and indicates that the fetus is not acidotic or significantly compromised at this moment. The negative predictive value is > 99%, meaning that > 99% of babies with normal BPP are healthy. However, the BPP assesses fetal status at a single point in time. Conditions can change rapidly in some pregnancies, which is why repeat testing is typically done twice weekly in high-risk pregnancies. Also, the BPP doesn't detect all types of problems - it's primarily assessing for acidosis and compromise.

Will I need to deliver early if my BPP is abnormal? It depends on the BPP score and your gestational age. A score of 4 or less typically prompts delivery if you're ≥ 34 weeks. A score of 6 usually requires repeat testing in 24 hours. If the repeat score is also abnormal, delivery is often considered. The decision balances the risks of continuing the pregnancy against the risks of premature delivery. For very preterm gestational ages (＜ 32-34 weeks), the decision is more complex and individualized based on your specific situation, the degree of abnormality, and other clinical factors.

• The biophysical profile (BPP) is a prenatal test combining four ultrasound assessments (breathing movements, body movements, tone, amniotic fluid) with one NST to evaluate fetal well-being, scored from 0-10.

• Scores of 8-10 are reassuring (normal), 6 is equivocal requiring repeat testing in 24 hours, and ≤ 4 is abnormal typically prompting delivery depending on gestational age.

• Primary indications include IUGR, preeclampsia, decreased fetal movement, diabetes, post-term pregnancy, oligohydramnios, prior fetal demise, and other high-risk conditions.

• The BPP has excellent negative predictive value (> 99%) - a normal BPP virtually excludes fetal acidosis, though it provides only a snapshot in time and requires repeat testing.

• Testing frequency ranges from twice weekly to daily depending on clinical situation, with more frequent testing for higher-risk conditions.

• Management of abnormal BPP scores depends on gestational age: ＜ 24 weeks (individualized, often intensive monitoring), 24-31 weeks (hospitalization, corticosteroids, individualized delivery timing), 32-33 weeks (consider delivery), ≥ 34 weeks (delivery typically recommended).

• Limitations include subjectivity of some components, fetal sleep state effects, maternal body habitus affecting visualization, interobserver variability, and time-consuming nature of the test.

• The test takes 30-45 minutes total, poses no risk to mother or fetus using standard ultrasound and external fetal heart rate monitoring, and is repeatable as often as clinically indicated.